Cipta Sarana Medika Tbk. vs Unilever Indonesia Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp63 (market cap 158.12B, 8.21M 24h volume), while Unilever Indonesia Tbk. trades at Rp1,670 (market cap 63.9T, 9.09M 24h volume). The key difference: Unilever Indonesia Tbk. is far larger — about 404.1× Cipta Sarana Medika Tbk.'s market cap, and Unilever Indonesia Tbk. is more actively traded (9.09M versus 8.21M). Which is the better fit depends on your goals.
| DKHH | UNVR | |
|---|---|---|
Market Cap | 158.12B | 63.9T |
Volume | 8.21M | 9.09M |
Lot | 82.15K | 90.94K |
Turnover | 515.2M | 15.25B |
Average Price | 62.72 | 1,677.47 |
Value | 515.2M | 15.25B |
Indicative Equilibrium Price | 63 | 1,670 |
Indicative Equilibrium Volume | 1.33K | 3.26K |
Trailing returns across standard periods
Latest headlines on both assets
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →PT Unilever Indonesia Tbk (the Company) was established on 5 December 1933 as Levers Zeepfabrieken N.V. by deed No. 23 of Mr. A.H. van Ophuijsen, a notary in Batavia, which was approved by the Gouverneur Generaal van Nederlandsch-Indie in letter No. 14 on 16 December 1933, registered at the Raad van Justitie in Batavia under No. 302 on 22 December 1933 and published in the Javasche Courant on 9 January 1934, Supplement No. 3.
Read more on UNVR →